Cited by — Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Comparison of safety profiles for dapagliflozin based on EMA and FDA safety issues: Challenges and future of post-marketing surveillance in Korea.
No admitted local citation edges point to this work yet.
